High-flow nasal oxygen therapy may not be superior to standard oxygen therapy after cardiac surgery

1. Routine high-flow nasal oxygen therapy (HFNOT) following extubation did not improve outcomes compared to standard oxygen therapy (SOT) in patients with an elevated risk of pulmonary complications undergoing cardiac surgery. Evidence Rating Level: 1 (Excellent) Pulmonary complications are common after cardiac surgery, particularly in high-risk groups such as smokers and those with preexisting…